Inve US ▾
OSOSCR

Oscar Health (OSCR) Q1 FY26 earnings call: guidance and Q&A

Earnings call· Mar 2026 (Q1 FY26)· Health Care· May 6, 2026

Source: earnings call transcript

Executive summary

Oscar Health Q1 FY26 — Strong Growth and Profitability Driven by Tech and Disciplined Execution

Oscar Health delivered strong Q1 FY26 results, driven by significant membership growth and improved profitability metrics, leveraging its tech-first approach and AI initiatives. The company reaffirmed its full-year guidance, anticipating meaningful profitability in 2026, while actively shaping the individual health insurance market through new platforms and policy advocacy.

Highlights

5
  • Revenue of $4.6 billion, an increase of 53% year-over-year.

  • SG&A ratio improved 60 basis points year-over-year to 15.2%.

  • MLR improved 490 basis points year-over-year to 70.5%.

  • Earnings from operations of $704 million, an increase of nearly 2.5x over the same period last year.

  • Membership grew to 3.2 million, a 56% increase year-over-year.

Concerns

2
  • Risk adjustment transfer tracking around 24% in Q1, higher than the full-year expectation of 20%.

  • Gradual churn of members throughout the year, consistent with pre-ARPA levels.

Guidance & targets

CategoryTargetConfidence
Total revenues
$18.7 billion to $19 billion
high materiality
High
Medical Loss Ratio (MLR)
82.4% to 83.4%
high materiality
High
SG&A expense ratio
15.8% to 16.3%
medium materiality
High
Earnings from operations
$250 million to $450 million
high materiality
High
Adjusted EBITDA
roughly $115 million higher than earnings from operations
high materiality
High

OSCR operating KPIs by quarter

OSCR operating KPIs stated on its earnings calls, by fiscal quarter
KPIThis call Mar 2026 Q1 FY26 Jun 2026 Q2 FY26Change vs prior quarter
Members
3.2M Oscar ended the first quarter with 3.2 million members, an increase of 56% year-over-year. Source: earnings call transcript
2.96M Oscar ended the second quarter with 2.96 million members, up 46% year-over-year. Source: earnings call transcript
-7.5%

Operating figures the company stated on at least two of the calls shown, checked against each call's transcript. Click a figure to read the sentence. A dash means it was not stated that quarter.

Product announcements

ProductTypeDetails
Real-time drug pricing featurelaunch
Bilingual voice agentsexpansion
ICHRA Xlaunch
Lucie Health Marketplacelaunch

Deals & partnerships

Other carriers, benefit brokers, ICHRA platforms Data exchange for ICHRA

Oscar launched ICHRA X to create a more consistent employee experience for ICHRA.

Allstate Health, Aflac, Guardian Ancillary and supplemental product offerings on Lucie Health Marketplace

Companies like Allstate Health, Aflac, and Guardian are joining the Lucie platform to provide additional benefit solutions.

Risks & headwinds

Member churn Throughout the balance of the year

Approximately 200,000 members churned between Q1 end and April 1, starting Q2 with 3 million paid members.

Mitigation:Expects gradual churn consistent with pre-ARPA levels; no unusual utilization patterns observed for churned members.

Risk adjustment uncertainty Q2 FY26 and beyond

Q1 risk adjustment transfer tracking around 24%, higher than the full-year expectation of 20%.

Mitigation:Waiting for further clarity with the first 2026 Wakely report in Q2; current accruals are based on pricing expectations and have not yet factored in potential favorability from market morbidity reports.

Market morbidity Full year 2026

Wakely's new report shows market contraction tracking in line to favorable to Oscar's 20% to 30% estimate, with market morbidity potentially up 2.9% to 6.5% in 2026.

Mitigation:Oscar's claims experience and third-party data point to market morbidity tracking in line to favorable with pricing expectations, potentially offering a tailwind. However, overall claims performance development is the most important factor.

What to watch in Q2 FY26

Market Morbidity Assessment

Q2 FY26 (with the first 2026 Wakely report)
Current in line to favorable with our expectations (Wakely report)
Target Further clarity and confirmation of favorable trends

Why it matters

Morbidity assumptions directly impact risk adjustment and profitability.

We look forward to further clarity with the first 2026 Wakely report in Q2.

Find out whether OSCR delivers this. Inve re-checks your case every morning.

Q&A highlights

Describe the behavior and expense accounting for the 200,000 members who churned between Q1 and April 1.

There were no unusual utilization patterns for churned members; most never made a payment. Claims are not paid once a member is delinquent, so no significant utilization was expected or observed for this group. The transition was in line with expectations.

“So I would say that for members who churned off, nothing unusual about any of the utilization patterns that we experienced in the first quarter. And those members, in general, the biggest portion of the drop-off really are people that never made a payment.”

asked by Jessica Tassan · answered by Richard Blackley

2 min read 5 chapters

Detailed narrative

Individual Market Dynamics and Policy

The individual health insurance market remains resilient with 23 million lives, reflecting a consumer shift towards choice and transparency. Oscar is actively engaging with federal and state policymakers to advance policies that enhance transparency, product choice, and innovation. Early reports from Wakely indicate market contraction is tracking in line with or favorably to Oscar's 20% to 30% estimate, suggesting a stable market environment.

Technology and AI-Driven Operations

Oscar is rapidly deploying advanced technology and AI solutions to optimize operations, reduce costs, and improve member experience. Recent innovations include a real-time drug pricing feature that predicts abandonment and guides members to lower-cost alternatives, and the scaling of new bilingual voice agents to enhance care navigation and speed to service. These initiatives are central to Oscar's strategy for continued expansion and efficiency.

ICHRA and Lucie Health Marketplace Initiatives

The Individual Coverage Health Reimbursement Arrangement (ICHRA) is gaining traction, prompting Oscar to launch ICHRA X, a data exchange designed to connect carriers, brokers, and platforms for a more consistent employee experience. Building on this, Oscar introduced the Lucie Health Marketplace, a carrier-agnostic shopping platform for ACA plans and ancillary products.

Lucie aims to empower consumers and brokers with personalized coverage options, representing a key step in Oscar's long-term vision for a consumer-driven health economy.

Cautious Approach to Risk Adjustment

Oscar adopted a cautious stance on risk adjustment in Q1 FY26, basing reserves on market morbidity assumptions consistent with its pricing strategy. Despite seasonally low medical claims in Q1, which led to a higher risk adjustment accrual, the company is encouraged by third-party data and its own claims experience.

These signals suggest market morbidity is tracking favorably, potentially offering a tailwind, though Oscar awaits further clarity from the Q2 Wakely report before adjusting accruals.

Membership Growth and Retention

Oscar concluded the first quarter with 3.2 million members, marking a 56% year-over-year increase, driven by strong open enrollment growth and effective retention strategies. The company began Q2 with 3 million paid members, aligning with expectations for gradual churn consistent with pre-ARPA levels. This record membership underscores the success of Oscar's strategic plan and its positioning for sustained growth and profitability.

Summary of the company's earnings call; see how call summaries are prepared. Not investment advice.